Hopwood Financial Services Inc. Purchases Shares of 950 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Hopwood Financial Services Inc. purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 950 shares of the exchange traded fund’s stock, valued at approximately $86,000.

Several other institutional investors have also added to or reduced their stakes in XBI. Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after acquiring an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at about $141,284,000. Proficio Capital Partners LLC raised its stake in shares of SPDR S&P Biotech ETF by 16,156.1% during the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock valued at $82,615,000 after acquiring an additional 911,686 shares during the last quarter. Mirae Asset Securities USA Inc. raised its stake in shares of SPDR S&P Biotech ETF by 50.0% during the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after acquiring an additional 300,000 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $55,529,000.

SPDR S&P Biotech ETF Trading Up 1.1 %

Shares of NYSEARCA:XBI opened at $87.15 on Thursday. The company has a market cap of $5.75 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. The company has a 50-day moving average price of $90.28 and a 200-day moving average price of $95.02. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.